SparingVision
PrivateLast Round
Series B
Sep 14, 2022
Total Funding Raised
$130.49M
Company Overview
SparingVision is a biotechnology company developing genomic medicines and gene-agnostic therapies for inherited retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SparingVision Comparables
Compare SparingVision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoscope Therapeutics Inc. | 86% | |
| Coave Therapeutics | 86% | |
| Restore Vision Inc. | 85% |
SparingVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 14, 2022 | ||||
| Series A | Oct 21, 2020 | ||||
| Grant | Jul 9, 2019 | ||||
| Grant | Jul 12, 2017 |
Key People
Founding team and executive leadership
SparingVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Programme d'Investissements d'Avenir | Series B |
| European Innovation Council Fund | Grant |
| Ministry of Higher Education and Research | Grant |
| Ysios Capital | Series A, Series B |
| 4BIO Capital | Series B, Series A |
| Sofimac Innovation | Series A |
| EIC Accelerator | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2025
Kalliopi 'Kali' Stasi appointed as the new Chief Medical Officer.
- May 19, 2025
Presented PRODYGY data and research update at ASGCT 2025.
SparingVision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SparingVision's valuation, stock price, and market status.
Is SparingVision a public or private company?
SparingVision is a private company.
What is the current stock price of SparingVision?
SparingVision is a private company with no public stock price. No recent secondary market data is available.
How much is SparingVision worth (valuation)?
Valuation information for SparingVision is not publicly available.
Can I buy SparingVision stock?
SparingVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SparingVision's last funding round?
SparingVision's most recent funding round was Series B on September 14, 2022.
Who are the main investors in SparingVision?
Key investors in SparingVision include 4Bio Capital, UPMC Enterprises, Jeito.
Will SparingVision IPO soon?
No public IPO plans have been announced for SparingVision.
How can I track SparingVision secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SparingVision's secondary market activity and sign up for updates.